GE HealthCare Technologies Inc. $GEHC Stock: Keybank National Association OH Lowers Position

Keybank National Association OH reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 48.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 136,739 shares of the company’s stock after selling 126,280 shares during the period. Keybank National Association OH’s holdings in GE HealthCare Technologies were worth $8,939,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of GEHC. State Street Corp raised its stake in shares of GE HealthCare Technologies by 1.6% during the 2nd quarter. State Street Corp now owns 20,861,566 shares of the company’s stock worth $1,335,349,000 after purchasing an additional 323,090 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC lifted its holdings in shares of GE HealthCare Technologies by 13.2% during the 2nd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,455,814 shares of the company’s stock valued at $861,307,000 after buying an additional 1,571,226 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of GE HealthCare Technologies by 2.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 5,399,439 shares of the company’s stock valued at $384,219,000 after buying an additional 105,995 shares in the last quarter. Van ECK Associates Corp grew its stake in shares of GE HealthCare Technologies by 4.1% in the 2nd quarter. Van ECK Associates Corp now owns 4,482,631 shares of the company’s stock valued at $286,933,000 after buying an additional 177,028 shares in the last quarter. Finally, Mizuho Markets Cayman LP grew its stake in shares of GE HealthCare Technologies by 173.2% in the 1st quarter. Mizuho Markets Cayman LP now owns 3,068,500 shares of the company’s stock valued at $218,416,000 after buying an additional 1,945,500 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $81.84 on Friday. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77. The firm’s fifty day simple moving average is $70.29 and its 200 day simple moving average is $70.10. The company has a current ratio of 1.30, a quick ratio of 1.01 and a debt-to-equity ratio of 0.86. The firm has a market capitalization of $37.00 billion, a PE ratio of 17.27, a PEG ratio of 2.08 and a beta of 0.65.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, October 28th. The company reported $1.34 EPS for the quarter, topping the consensus estimate of $1.20 by $0.14. The firm had revenue of $5.51 billion for the quarter, compared to the consensus estimate of $5.35 billion. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The business’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the firm posted $1.07 EPS. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 5.02 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be given a $0.04 dividend. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.38%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on GEHC shares. Weiss Ratings upgraded GE HealthCare Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, October 6th. BTIG Research lifted their target price on shares of GE HealthCare Technologies from $75.00 to $83.00 and gave the company a “buy” rating in a research note on Wednesday, October 28th. Hovde Group started coverage on shares of GE HealthCare Technologies in a research note on Friday, July 17th. They issued a “market perform” rating and a $14.00 target price for the company. Zacks Research raised shares of GE HealthCare Technologies from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 11th. Finally, JPMorgan Chase & Co. increased their price target on shares of GE HealthCare Technologies from $70.00 to $80.00 and gave the stock a “neutral” rating in a research note on Thursday, October 29th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $82.17.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.